Psychotherapists routinely work with clients who are taking psychiatric medications, yet most have received little formal training in psychopharmacology. As a result, clinicians may feel uncertain about how to interpret behavioural changes during therapy, respond to client questions about their medications, recognize adverse effects that emerge between sessions, or communicate effectively with prescribing professionals. These uncertainties can weaken the therapeutic alliance, complicate case formulation, and reduce the coordination of care.
This training provides psychotherapists with practical, clinically relevant psychopharmacology knowledge that directly supports psychotherapeutic processes and methods. Participants will learn how commonly prescribed psychiatric medications influence mood, cognition, sleep, anxiety, attention, and psychotic symptoms, and how these effects present in session. The training emphasizes the observable clinical effects, side effects, and response patterns that psychotherapists are uniquely positioned to monitor over the course of treatment.
The workshop also addresses how to integrate medication-related content into psychotherapy: exploring clients' expectations and beliefs about medication, working with adherence concerns as part of the therapeutic process, supporting an expanded informed consent process, and applying ethical and scope-of-practice principles when medication topics arise. Participants will develop skills for recognizing medication-related concerns, communicating observations to prescribers using a complementary-colleague model, and knowing when consultation with a prescriber is required.
By the end of the training, psychotherapists will have greater confidence in integrating medication awareness into their psychotherapeutic work and contributing to coordinated, patient-centred care.
